Skip to main content
See every side of every news story
Published • loading... • Updated

A Common Diabetes Drug Reduced Inflammatory Cell Clusters Tied to Heart Disease in a Small Human Trial

In a pilot study of 16 women with obesity and prediabetes, empagliflozin lowered circulating monocyte-platelet aggregates within two weeks, an effect dieting did not produce.
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Scientific Inquirer broke the news on Monday, November 16, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal